Currently available GLP-1 receptor agonists in the UK include: Exenatide (injectable formulations) Liraglutide (Victoza for diabetes
Cuglievan B, Kantarjian H, Armstrong S, Rubnitz J, Zwaan M, Dinardo C, Cooper T, Pollard J, Kadia T, Guest E, Short N, McCall D, Daver N, Nunez C, Haddad F, Garcia M, Bhalla K, Maiti A, Catueno S, Fiskus W, Gibson A, Roth M, Khazal S, Tewari P, Abbas H, Bourgeois W, Andreeff M , Gruber T, Shukla N, Truong D, Connors J, Joseph Ludwig J, Stutterheim J, Salzer E, Dam KJ, Sasaki K, Mahadeo K, Tasian S, Borthakur G, Dickson S, Faulk K, Jain N, Jabbour E, Meshinchi S, Garcia Manero G, Ravandi F, Stein E, Kolb A, Issa G
Antioxidant Effects : Given that amlodipine has antioxidant properties of its own, as evidenced by its ability to reduce oxidative stress, adding an external source of antioxidants like glutathione may complement its effects
Inhibitors of the nuclear scaffold protease block apoptosis of myeloid leukemic lymphocytes in vitro